Eta Atolia is the Founder of TareBio, a life sciences venture at the intersection of immunology and biotechnology, bringing deep scientific expertise to address unmet needs in human health.

Eta earned her PhD in Immunology from UCLA in 2023 through the prestigious UCLA-Caltech Medical Scientist Training Program (MSTP), where she also pursued her MD, building a rigorous foundation in translational science.

With 9 published research works and over 667 academic citations, Eta bridges cutting-edge immunology research and real-world biomedical innovation, a rare combination in early-stage biotech founding teams.

Eta's scientific work was conducted at UCLA and MIT-affiliated institutions, equipping her with the research rigor and network to translate laboratory discoveries into therapeutic applications.

Through TareBio, Eta is working to advance immunology-driven solutions, leveraging her academic training and publication record to build a scientifically credible and impactful biotech company.